3.1.3.56	Carcinoma	https://pubmed.ncbi.nlm.nih.gov/25759212/	A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh.	ongoing research	1	
3.1.3.56	Carcinoma	https://pubmed.ncbi.nlm.nih.gov/25759212/	A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh.	unassigned	-	
3.1.3.56	Carcinoma, Squamous Cell	https://pubmed.ncbi.nlm.nih.gov/25759212/	A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh.	ongoing research	1	
3.1.3.56	Carcinoma, Squamous Cell	https://pubmed.ncbi.nlm.nih.gov/25759212/	A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh.	unassigned	-	
3.1.3.56	Neoplasm Metastasis	https://pubmed.ncbi.nlm.nih.gov/33798953/	A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR.	causal interaction	4	
3.1.3.56	Neoplasm Metastasis	https://pubmed.ncbi.nlm.nih.gov/33798953/	A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR.	unassigned	-	
3.1.3.56	Neoplasms	https://pubmed.ncbi.nlm.nih.gov/33798953/	A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR.	causal interaction	4	
3.1.3.56	Neoplasms	https://pubmed.ncbi.nlm.nih.gov/33798953/	A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR.	unassigned	-	
3.1.3.56	Oculocerebrorenal Syndrome	https://pubmed.ncbi.nlm.nih.gov/23692838/	A novel OCRL1 gene mutation in a Turkish child with Lowe syndrome.	causal interaction	3	
3.1.3.56	Oculocerebrorenal Syndrome	https://pubmed.ncbi.nlm.nih.gov/23692838/	A novel OCRL1 gene mutation in a Turkish child with Lowe syndrome.	therapeutic application	1